Welcome to the March 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
-
Paper of the MonthEAN NewsResearchFeatured SliderResearch Paper of the Month: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s disease in the UK
Our paper of the month for March is a phase 3 multicentre, double-blind, randomised trial investigating whether treatment with exenatide can slow the progression of Parkinson’s disease. -
Executive PageEAN NewsFeatured SliderExecutive Page: “on a Brain Mission” – EAN Treasurer on her first six months in office
EAN Treasurer, Jana Midelfart-Hoff reviews her "fantastic experience" in office over the last six months, representing the EAN and the Brain Health Mission on various levels -
Welcome to the February 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsFeatured Slider
Research Papers of the Month: Safety and efficacy of satralizumab/nipocalimab in patients with generalised myasthenia gravis
For February we have selected two co-papers of the month, each of which examines the safety and efficacy of a specific drug in the treatment of patients with generalised myasthenia gravis. -
Executive PageEAN NewsEAN Congress newsFeatured SliderExecutive Page: Submit, register, and join us for our 11th Congress in Helsinki!
EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved! -
Welcome to the first edition of the President’s Corner, a new article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease
Our paper of the month compares drug prescription prior to the clinical onset of sporadic Creutzfeldt-Jakob disease in patients versus matched controls aiming to uncover potential risk or protective factors. -
AdvocacyExecutive PageBrain HealthEAN NewsEAN Congress newsFeatured SliderExecutive Page: EAN President reviews a milestone year and looks ahead to exciting plans for 2025
EAN President, Prof. Elena Moro, looks back at some highlights of a successful 10th anniversary year for the EAN, and ahead to some exciting plans for 2025. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2024. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease
Our paper of the month highlights the findings of the stage 2 interim analysis from the first cycle of MND SMART, a phase 3, multi-arm, randomised, adaptive platform trial conducted across 20 centres in the UK. -
Executive PageEAN NewsFeatured SliderExecutive Page: RRFS committed to promoting equal access among its diverse community
Dr Giacomo Sferruzza, the new EAN Resident & Research Fellow Section (RRFS) Chair, gives an overview of the RRFS Office team, and their aims and priorities for the term ahead. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Safety and efficacy of evobrutinib in relapsing multiple sclerosis
Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.
-
Executive PageBrain HealthEAN NewsEAN NewsFeatured SliderExecutive Page: New EAN President-Elect names inclusivity, brain health, and international collaboration as aims for his new role
Prof. Kailash Bhatia, Professor of Clinical Neurology at the Department of Clinical and Movement Neuroscience of the Institute of Neurology, UCL, Queen Square, London, was voted in as President-Elect of the EAN at the EAN Congress 2024.